ACS Nano,
Год журнала:
2024,
Номер
18(52), С. 35671 - 35683
Опубликована: Дек. 19, 2024
Photodynamic
therapy
(PDT)
using
oxygen-dependent
type
II
photosensitizers
is
frequently
limited
by
the
hypoxic
microenvironment
of
solid
tumors.
Type
I
show
oxygen-independent
reactive
oxygen
species
(ROS)
generation
upon
light
irradiation
but
still
face
challenges
aggregation-caused
quenching
(ACQ)
and
low
efficiency
to
produce
ROS.
Herein,
we
first
prepare
an
efficient
photosensitizer
from
a
perylene
derivative
via
intramolecular
donor-acceptor
binding
sulfur
substitution,
which
significantly
enhance
intersystem
crossing
between
singlet
triplet
states
electron
transfer
capability.
After
reaction
with
photosensitizer,
covalent
organic
framework
(COF)
nanophotosensitizer
formed
alternated
motifs
in
same
layer
staggered
AB
stacking
layers
avoid
ACQ.
The
exhibits
high-efficiency
(1O2)
superoxide
anion
radicals
(O2•-)
mechanism
under
normoxia
exposure
irradiation.
Under
hypoxia,
massive
O2•-
can
be
produced
continuously.
potent
ROS
capability
results
cellular
apoptosis
immunogenic
cell
death
(ICD)
efficiently.
combination
immune
checkpoint
inhibitors,
tumor
immunosuppressive
reversed,
effectively
ablates
bulky
primary
tumors
suppresses
metastases
photodynamic
immunotherapy.
COF
nanophotosensitizers
represent
promising
strategy
boost
immunotherapy
Advanced Functional Materials,
Год журнала:
2024,
Номер
34(36)
Опубликована: Март 29, 2024
Abstract
Fluorescence
imaging
in
the
second
near‐infrared
window
(NIR‐II,
1000–1700
nm)
has
aroused
immense
attention
for
biomedical
applications,
offering
exceptional
advantages
such
as
ultra‐low
photon
scattering
and
increased
tissue
penetration.
Among
NIR‐II‐emitted
organic
dyes,
Boron
dipyrromethene
(BODIPY),
emerged
a
noteworthy
candidate.
BODIPY,
distinguished
by
its
controllable
molecular
structure
optical
properties,
outstanding
fluorescence
quantum
yields,
high
molar
absorption
coefficients,
remarkable
chemical
stability,
undergone
comprehensive
investigation
extensive
exploration
within
realm
of
biological
theranostics.
This
work
aims
to
provide
summary
advancements
development
design
strategies
NIR‐II
BODIPY
fluorophores
tailored
advanced
phototheranostics.
Initially,
elucidates
several
representative
strategies,
concluding
electron‐programming
strategy,
extension
conjugated
backbone,
J‐aggregation
strategic
establishment
activatable
fluorophores,
which
enhance
skeletons.
Subsequently,
developments
fluorescent
BODIPY‐based
nanoplatforms
applications
are
intricately
elaborated.
In
conclusion,
this
outlines
future
efforts
directions
refining
meet
evolving
clinical
demands.
It
is
anticipated
that
contribution
may
feasible
reference
thereby
advancing
their
potential
practices.
Advanced Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 9, 2025
Abstract
Photodynamic
therapy
(PDT)
holds
significant
promise
for
antibacterial
treatment,
with
its
potential
markedly
amplified
when
using
Type
I
photosensitizers
(PSs).
However,
developing
PSs
remains
a
challenge
due
to
lack
of
reliable
design
strategy.
Herein,
PS
nanocluster
is
developed
via
self‐assembly
zwitterionic
small
molecule
(C3TH)
superior
PDT
in
vivo.
Mechanism
studies
demonstrate
that
unique
cross‐arranged
C3TH
within
not
only
shortens
intermolecular
distance
but
also
inhibits
electronic‐vibrational
coupling,
thus
facilitating
photoinduced
electron
transfer
form
radical
cation
and
anion
autoionization
reaction.
Subsequently,
these
highly
oxidizing
or
reducing
radicals
engage
cascade
photoredox
generate
efficient
·OH
O
2
‾·.
As
result,
nanoclusters
achieve
97.6%
efficacy
against
MRSA
at
an
ultralow
dose,
surpassing
the
commercial
antibiotic
Vancomycin
by
more
than
8.8‐fold.
These
findings
deepen
understanding
PDT,
providing
novel
strategy
PSs.
Materials Today Bio,
Год журнала:
2024,
Номер
28, С. 101217 - 101217
Опубликована: Авг. 24, 2024
Cold
exposure
therapy
(CE),
as
an
inexpensive
method,
has
shown
great
potential
in
cancer
therapy.
Exploring
the
combined
anti-tumor
mechanism
of
CE
and
traditional
therapies
(such
photodynamic
(PDT))
is
exciting
promising.
Here,
a
bionic
aggregation-induced
emission
photosensitizer
system
(named
THL)
designed
for
to
enhance
immunotherapy.
THL
inherits
homologous
targeting
ability
tumor
derived
exosomes,
promoting
enrichment
at
site.
Under
external
illumination,
generates
hydroxyl
radicals
superoxide
anions
through
type
I
PDT.
In
addition,
mice
are
pretreated
with
cold
exposure,
which
promotes
mediated
PDT
reactive
oxygen
species
(ROS)
generation
by
reducing
production
ATP
GSH
tissue.
This
combination
increases
ROS
within
tumor,
inhibits
growth
distant
tumors,
recurrent
rechallenged
tumors
number
cytotoxic
CD8+T
cells
memory
T
cells.
Compared
alone,
shows
greater
advantages
The
strategy
provides
new
ideas
Green Chemistry,
Год журнала:
2024,
Номер
26(21), С. 10739 - 10773
Опубликована: Янв. 1, 2024
This
paper
summarizes
the
latest
research
progress
in
selective
photocatalytic,
electrocatalytic,
and
photoelectrocatalytic
oxidation
of
HMF,
along
with
reaction
mechanisms,
advantages,
challenges
faced
during
HMF
oxidation.
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 7, 2025
Semiconducting
open-shell
radicals
(SORs)
have
promising
potential
for
the
development
of
phototheranostic
agents,
enabling
tumor
bioimaging
and
boosting
tumorous
reactive
oxygen
species
(ROS).
Herein,
a
new
class
semiconducting
perylene
diimide
(PDI),
designated
as
PDI(Br)n
with
various
numbers
bromine
(Br)
atoms
modified
on
PDI's
bay/ortho
positions
is
reported.
demonstrated
to
transform
into
radical
anion,
[PDI(Br)n]•-,
in
reducing
solution,
typical
g-value
2.0022.
Specifically,
[PDI(Br)4/6]•-
generated
weakly
reductive
tumor-mimicking
solution
exhibits
high
stability
air.
Quantum
chemical
kinetic
simulation
ultrafast
femtosecond
transient
absorption
spectroscopy
indicate
that
[PDI(Br)6]•-
has
low
π-π
stacking
energy
(0.35
eV),
fast
electron
transfer
rate
(192.4
ps)
gap
PDI(Br)6
(ΔES1,
T1
=
1.307
eV,
ΔES1,
T2
0.324
eV)
respectively,
which
together
result
excited-state
charge
characters.
The
nanoparticle
radicals,
[PDI(Br)6]
NPs•-,
specifically
enable
chemodynamic
type-I
photodynamic
ROS
generation
tumors,
including
superoxide
hydroxyl
elicit
immunogenic
cell
death
effect.
Also,
NPs•-
facilitate
activatable
bioimaging-guided
therapy
due
their
photoacoustic
signal
at
808
nm
NIR-II
emission
1115
nm.
work
paves
way
design
SORs
precise
cancer
theranostics.
Molecules,
Год журнала:
2025,
Номер
30(7), С. 1571 - 1571
Опубликована: Март 31, 2025
Photodynamic
therapy
(PDT)
is
a
therapeutic
method
based
on
the
interaction
between
light
and
photosensitizer.
Supported
by
nanoparticles,
this
represents
promising
interdisciplinary
approach
for
treatment
of
many
diseases.
This
article
reviews
latest
2024
developments
in
design
applications
nanoparticles
dedicated
to
stand-alone
PDT
breast
cancer.
Strategies
improve
efficacy
enhancing
reactive
oxygen
species
(ROS)
production,
precise
delivery
photosensitizers
their
stabilization
systemic
circulation
are
discussed,
among
others.
Results
from
preclinical
studies
indicate
significant
improvements
efficacy,
including
inhibition
tumor
growth,
reduction
metastasis
improvement
immune
microenvironment.
The
potential
these
technologies
expand
medicine
need
further
clinical
trials
confirm
safety
highlighted.
Chemical Science,
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 1, 2024
Bridge-assisted
superexchange
coupling
capable
of
long-range
electron
transfer
proves
to
be
effective
for
charge
separation.
However,
the
exploitation
this
photochemical
process
in
engineering
reactive
oxygen
species
(ROS)
production
remains
unexplored.
Herein,
piperazine
serves
as
a
bridging
unit
facilitate
cascade
from
donor
site
(CO)
acceptor
(CN)
within
COCN
molecule,
ultimately
boosting
generation
superoxide
radicals
(O
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 13, 2025
Abstract
Photodynamic
therapy
holds
great
potentials
in
cancer
treatment,
yet
its
effectiveness
hypoxic
solid
tumor
is
limited
by
the
oxygen‐dependence
and
insufficient
oxidative
potential
of
conventional
type
II
reactive
oxygen
species
(ROS).
Herein,
study
reports
a
supramolecular
photosensitizer,
BSA@TPE‐BT‐SCT
NPs,
through
encapsulating
aggregation‐enhanced
emission
photosensitizer
bovine
serum
albumin
(BSA)
to
significantly
enhance
ROS,
particularly
less
oxygen‐dependent
I
ROS
for
photodynamic
immunotherapy.
The
abundant
generated
NPs
induce
multiple
forms
programmed
cell
death,
including
apoptosis,
pyroptosis,
ferroptosis.
These
multifaceted
deaths
synergistically
facilitate
release
damage‐associated
molecular
patterns
antitumor
cytokines,
thereby
provoking
robust
immunity.
Both
vitro
vivo
experiments
confirmed
that
elicited
immunogenic
dendritic
maturation,
activate
T
cell,
reduce
myeloid‐derived
suppressor
cells,
leading
inhibition
both
primary
distant
tumors.
Additionally,
BSA@TPE‐BT‐SCP
also
exhibited
excellent
performance
humanized
mice
model,
evidenced
reduction
senescent
cells
among
these
activated
cells.
findings
advance
development
photosensitizers
unveil
important
role
enhancing
immunogenicity.